This variation affects:
Other names:
rs863225046 is a genetic variant on gene SCN4A associated with Congenital myasthenic syndrome 16 and Hyperkalemic periodic paralysis.
This variant is located on chromosome 17. The variations at position 63941912 are the genetic letters
Since humans have each twice (one from each parent), these letter-variations occur on both chromosomes. People can have the same or different letters on both chromosomes. Every person's individual variation combination is referred to as genotype. For variant rs863225046 there are 0 currently known genotypes .
rs863225046 is located on gene SCN4A in chromsome 17. Use the genome browser to explore the location of rs863225046 and its genetic neighbourhood.
rs863225046 affects the following conditions and traits:
rs863225046 affects the following conditions:
We do not have any data that links rs863225046 to any drugs.
rs863225046 is commonly tested together with other variants on the same gene.
This interactive browser visualizes what no human can see with the naked eye - our DNA. From a down to a specific position on a . The position you are looking at here is the exact location of variant rs on gene SCN4A. Explore more variants and their effects on the body by browsing left and right along the DNA strand.
Mutations are changes in genes and genetic variations are differences in the DNA among people. Variants are tiny changes in just one piece of the DNA while haplotypes are groups of these changes that usually come together.
Dr. Wallerstorfer
The different genotypes of variant rs863225046 can affect the likelyhood of developing certain traits or conditions. Current research shows that 2 conditions and 0 traits are associated with rs863225046. The following table shows the relationship between genotypes and conditions and traits.
Genetic variants can influence how our body reacts to certain drugs. The presence of specific genetic variants can increase or decrease the efficiency and effectiveness of a drug, impacting how well it works inside our system. Additionally, certain genetic variants can heighten or lessen the toxicity of a drug, thereby affecting the risk of unwanted side effects. They can also alter how a drug is metabolized, which influences the appropriate dosage one should receive.
Dr. Wallerstorfer
Clinical Testing
Scientific Studies
Biological Male Symbol
Biological Female Symbol
Unisex Symbol for both Genders
Variants can be classified either based on clinical tests or scientific studies. In the classification based on clinical tests, the variants are divided into five categories from Disease Causing (harmful) to No Effect (not harmful). This classification is based on family histories, laboratory tests and computer predictions and is intended to help doctors make medical decisions. The aim is to recognize the immediate health impact of variants on the human body. Classification based on scientific studies, however, is about understanding the long-term effects. It aims to identify the influence of genetic variants in conditions, traits, and evolution. Variants are classified into different categories based on their functional impact: Loss-of-Function (reduced gene activity), Gain-of-Function (increased gene activity), Neutral (no significant impact) and Evolutionary Conservation. This classification uses experimental data, population studies, and computational analyses.
Genotype
C
C
Level of evidence
No Effect
Unisex
1 Sources
Participants: 0
The genotype with the letters C/C is thought to have no effect on your disease risk. Carriers of this genetic result are usually not at risk of developing the disease.
Genotype
T
T
Level of evidence
Disease causing
Unisex
1 Sources
Participants: 0
The genotype with the letters T/T is considered disease causing. Carriers of this genetic result are typically affected by the disease.
Genotype
C
T
Level of evidence
Carrier with no risk
Unisex
1 Sources
Participants: 0
The genotype with the letters C/T has no effect on your disease risk. Carriers of this genetic result are usually not at risk of developing the disease.
Genotype
C
C
Level of evidence
No Effect
Unisex
1 Sources
Participants: 0
The genotype with the letters C/C is thought to have no effect on your disease risk. Carriers of this genetic result are usually not at risk of developing the disease.
Genotype
T
T
Level of evidence
Unknown effect
Unisex
1 Sources
Participants: 0
The genotype with the letters T/T has an unknown effect on your disease risk. This means that the scientific evidence is still somewhat unclear about its effect.
Genotype
C
T
Level of evidence
Unknown effect
Unisex
1 Sources
Participants: 0
The genotype with the letters C/T has an unknown effect on your disease risk. This means that the scientific evidence is still somewhat unclear about its effect.
rs863225046 is commonly tested together with other variants on the same gene.
Diseases and traits are often influenced by multiple genetic variants. To better understand how genetics affects certain diseases and traits, it is important to consider these additional factors. The following table shows other variants that are also associated with the same diseases and traits as rs863225046.
Knowing your genome can actually tell you a lot about your ancestors.
The prevalence of the different genotypes is based on the native inhabitants of a region. In the map below you see how common each genotype is in the native inhabitants of those regions. Since genetic material is passed down form generation to generation, your DNA shows traces of the geographical origins of your ancestors.
This data is based on “The 1000 Genomes Project” which established one of the most detailed overviews of human genetic variations across the globe. The regions are broadly categorized into five continental groups: Africa, America, Europe, South Asia and East Asia. All continental groups together display the global prevalence. Click through the regions, to learn more about the local prevalence of the possible genotypes.
At present, there is no distribution data available for SNP 863225046. 863225046.